Khalid Islam insider trades
Open-market stock purchases and sales by Khalid Islam, Director at Gain Therapeutics, Inc, from SEC Form 4 filings since Jul 3, 2017.
Track record: 100% of 1 scored buy are up 5% or more since purchase, averaging +29%.
Open-market stock purchases and sales by Khalid Islam, Director at Gain Therapeutics, Inc, from SEC Form 4 filings since Jul 3, 2017.
Track record: 100% of 1 scored buy are up 5% or more since purchase, averaging +29%.